Craft

Chembio

Revenue

$49.5 M

FY, 2022

Chembio Summary

Company Summary

Overview
Chembio Diagnostics is a point-of-care diagnostics company focused on infectious diseases. It offers a DPP technology, a diagnostic platform that uses fingertip blood, nasal swabs, and other sample types. The platform addresses sexually transmitted infections, tropical and fever diseases, respiratory diseases, etc.
Type
Subsidiary
Status
Active
Founded
1986
HQ
Medford, NY, US | view all locations
Website
https://chembio.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Javan Esfandiari

    Javan Esfandiari, Executive Vice President, Chief Science & Technology Officer, Chief Operations Officer

  • Tom Ippolito

    Tom Ippolito, Vice President, Quality and Regulatory Affairs

Operating MetricsView all

Trademarks

4

FY, 2022

Product Types

5

FY, 2022

Facilities Leased (Corporate Headquarters), sq.ft.

70K

FY, 2022

LocationsView all

4 locations detected

  • Medford, NY HQ

    United States

    3661 Horseblock Road

  • Boston, MA

    United States

    123 Waverly St

  • Rio de Janeiro, RJ

    Brazil

    Estr. dos Bandeirantes, 11 - 742 - Taquara

  • Berlin, BE

    Germany

    Schwarzschildstraße 1

Chembio Financials

Summary Financials

Revenue (FY, 2022)
$49.5M
Gross profit (FY, 2022)
$10.9M
Net income (FY, 2022)
($23.3M)
Cash (FY, 2022)
$18.2M
EBIT (FY, 2022)
($23.6M)

Footer menu